 Alvaro Proano Falconi
Concepts (110)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tuberculosis, Pulmonary | 4 | 2018 | 106 | 1.620 |
Why?
| | Cough | 3 | 2018 | 58 | 1.510 |
Why?
| | Antitubercular Agents | 4 | 2018 | 89 | 1.270 |
Why?
| | Infant, Very Low Birth Weight | 2 | 2016 | 58 | 0.880 |
Why?
| | Growth Disorders | 2 | 2016 | 67 | 0.880 |
Why?
| | Infant Mortality | 2 | 2022 | 65 | 0.830 |
Why?
| | Perinatal Mortality | 1 | 2022 | 4 | 0.740 |
Why?
| | Neonatology | 1 | 2022 | 16 | 0.740 |
Why?
| | Racism | 1 | 2022 | 61 | 0.670 |
Why?
| | Blepharoptosis | 1 | 2020 | 13 | 0.660 |
Why?
| | Lymphoproliferative Disorders | 1 | 2020 | 27 | 0.650 |
Why?
| | Fever | 1 | 2020 | 112 | 0.620 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 2020 | 110 | 0.610 |
Why?
| | Liver Transplantation | 1 | 2020 | 174 | 0.560 |
Why?
| | Peru | 6 | 2019 | 15 | 0.560 |
Why?
| | Tuberculosis | 2 | 2017 | 133 | 0.530 |
Why?
| | Computer Simulation | 2 | 2017 | 290 | 0.520 |
Why?
| | Energy Intake | 1 | 2016 | 186 | 0.450 |
Why?
| | Extensively Drug-Resistant Tuberculosis | 1 | 2014 | 5 | 0.440 |
Why?
| | Tuberculosis, Multidrug-Resistant | 1 | 2014 | 30 | 0.430 |
Why?
| | Eponyms | 1 | 2014 | 1 | 0.430 |
Why?
| | Polycythemia | 1 | 2014 | 10 | 0.420 |
Why?
| | Altitude Sickness | 1 | 2014 | 10 | 0.420 |
Why?
| | Infant, Small for Gestational Age | 1 | 2014 | 35 | 0.420 |
Why?
| | Patients | 1 | 2014 | 52 | 0.410 |
Why?
| | Child Development | 1 | 2016 | 215 | 0.410 |
Why?
| | Education, Medical, Undergraduate | 1 | 2014 | 85 | 0.400 |
Why?
| | Postoperative Complications | 1 | 2020 | 1099 | 0.400 |
Why?
| | Students, Medical | 1 | 2014 | 157 | 0.370 |
Why?
| | Infant, Newborn | 5 | 2023 | 2913 | 0.340 |
Why?
| | Infant, Premature | 1 | 2014 | 331 | 0.340 |
Why?
| | Humans | 19 | 2024 | 53230 | 0.300 |
Why?
| | Prospective Studies | 4 | 2019 | 2411 | 0.280 |
Why?
| | Female | 10 | 2023 | 28782 | 0.220 |
Why?
| | Male | 9 | 2023 | 27435 | 0.220 |
Why?
| | Mycobacterium tuberculosis | 2 | 2016 | 250 | 0.220 |
Why?
| | Telemedicine | 2 | 2024 | 512 | 0.200 |
Why?
| | Developing Countries | 1 | 2024 | 66 | 0.200 |
Why?
| | Premature Birth | 1 | 2023 | 149 | 0.180 |
Why?
| | Infant | 3 | 2021 | 3805 | 0.180 |
Why?
| | Adult | 7 | 2023 | 14534 | 0.180 |
Why?
| | Chagas Disease | 1 | 2021 | 4 | 0.170 |
Why?
| | Pregnancy Complications, Parasitic | 1 | 2021 | 4 | 0.170 |
Why?
| | Infectious Disease Transmission, Vertical | 1 | 2021 | 18 | 0.170 |
Why?
| | Birth Weight | 2 | 2023 | 119 | 0.170 |
Why?
| | Pregnancy | 3 | 2023 | 2608 | 0.160 |
Why?
| | Young Adult | 3 | 2023 | 4511 | 0.160 |
Why?
| | Deep Sedation | 1 | 2019 | 5 | 0.150 |
Why?
| | Middle Aged | 4 | 2019 | 13419 | 0.140 |
Why?
| | Hypertension | 1 | 2023 | 554 | 0.140 |
Why?
| | Biopsy | 1 | 2020 | 600 | 0.140 |
Why?
| | Cohort Studies | 3 | 2019 | 1557 | 0.140 |
Why?
| | Longitudinal Studies | 2 | 2019 | 774 | 0.140 |
Why?
| | Disease Transmission, Infectious | 1 | 2017 | 13 | 0.140 |
Why?
| | Logistic Models | 2 | 2019 | 947 | 0.130 |
Why?
| | Diagnosis, Differential | 1 | 2020 | 1038 | 0.130 |
Why?
| | Circadian Rhythm | 1 | 2017 | 91 | 0.130 |
Why?
| | Predictive Value of Tests | 2 | 2016 | 934 | 0.120 |
Why?
| | Pyrazinamide | 1 | 2016 | 7 | 0.120 |
Why?
| | Public Health | 2 | 2016 | 231 | 0.120 |
Why?
| | Clinical Protocols | 1 | 2016 | 109 | 0.120 |
Why?
| | Drug Resistance, Bacterial | 1 | 2016 | 79 | 0.120 |
Why?
| | Microbial Sensitivity Tests | 1 | 2016 | 274 | 0.110 |
Why?
| | Incidence | 1 | 2018 | 1085 | 0.110 |
Why?
| | User-Computer Interface | 1 | 2014 | 80 | 0.100 |
Why?
| | History, 20th Century | 1 | 2014 | 97 | 0.100 |
Why?
| | Health Promotion | 1 | 2016 | 278 | 0.100 |
Why?
| | Magnetic Resonance Imaging | 1 | 2020 | 1583 | 0.100 |
Why?
| | Aged, 80 and over | 2 | 2019 | 3494 | 0.100 |
Why?
| | Follow-Up Studies | 1 | 2018 | 2318 | 0.090 |
Why?
| | Tomography, X-Ray Computed | 1 | 2018 | 1180 | 0.090 |
Why?
| | Brain | 1 | 2020 | 1350 | 0.090 |
Why?
| | Gastroenterology | 1 | 2011 | 36 | 0.080 |
Why?
| | Social Media | 1 | 2011 | 125 | 0.070 |
Why?
| | Treatment Outcome | 1 | 2019 | 5595 | 0.070 |
Why?
| | Aged | 2 | 2019 | 10429 | 0.060 |
Why?
| | Adolescent | 1 | 2017 | 6907 | 0.060 |
Why?
| | Retrospective Studies | 1 | 2016 | 6819 | 0.050 |
Why?
| | Risk Factors | 2 | 2023 | 4017 | 0.050 |
Why?
| | Child Health Services | 1 | 2024 | 79 | 0.050 |
Why?
| | Gestational Age | 1 | 2023 | 394 | 0.050 |
Why?
| | Blood Pressure | 1 | 2023 | 518 | 0.040 |
Why?
| | Parasite Load | 1 | 2021 | 2 | 0.040 |
Why?
| | Pediatrics | 1 | 2024 | 307 | 0.040 |
Why?
| | Body Mass Index | 1 | 2023 | 717 | 0.040 |
Why?
| | Neuromuscular Blocking Agents | 1 | 2019 | 10 | 0.040 |
Why?
| | APACHE | 1 | 2019 | 26 | 0.040 |
Why?
| | Rural Population | 1 | 2024 | 596 | 0.040 |
Why?
| | Hypnotics and Sedatives | 1 | 2019 | 74 | 0.040 |
Why?
| | Analgesics | 1 | 2019 | 104 | 0.030 |
Why?
| | Odds Ratio | 1 | 2019 | 567 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2019 | 243 | 0.030 |
Why?
| | Antipsychotic Agents | 1 | 2019 | 233 | 0.030 |
Why?
| | Caribbean Region | 1 | 2016 | 6 | 0.030 |
Why?
| | Latin America | 1 | 2016 | 11 | 0.030 |
Why?
| | Respiration, Artificial | 1 | 2019 | 293 | 0.030 |
Why?
| | Spectrophotometry | 1 | 2016 | 26 | 0.030 |
Why?
| | Reference Standards | 1 | 2016 | 52 | 0.030 |
Why?
| | Sputum | 1 | 2016 | 65 | 0.030 |
Why?
| | Calibration | 1 | 2016 | 58 | 0.030 |
Why?
| | Area Under Curve | 1 | 2016 | 185 | 0.030 |
Why?
| | ROC Curve | 1 | 2016 | 246 | 0.030 |
Why?
| | Biomedical Research | 1 | 2016 | 267 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2016 | 1219 | 0.020 |
Why?
| | Child | 1 | 2024 | 7379 | 0.020 |
Why?
| | Blogging | 1 | 2011 | 2 | 0.020 |
Why?
| | Access to Information | 1 | 2011 | 21 | 0.020 |
Why?
| | Information Storage and Retrieval | 1 | 2011 | 63 | 0.020 |
Why?
| | Education, Medical, Continuing | 1 | 2011 | 76 | 0.020 |
Why?
| | Medical Informatics | 1 | 2011 | 58 | 0.020 |
Why?
|
|
Proano Falconi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|